Clinical Trial Update: Continuing vs Intermittent Trabectedin in Patients With Advanced Soft Tissue Sarcoma [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing continuing versus intermittent administration of trabectedin in patients with advanced soft tissue sarcoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma
• Uterine Sarcoma

Drugs mentioned

• Yondelis (trabectedin)

Snippet

Sponsor: Centre Oscar Lambret | Conditions: Soft Tissue Sarcoma, Uterine Sarcoma | Phase 2 | Status: COMPLETED